Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

2(28.6%)

Phase 2

1(14.3%)

7Total

N/A(4)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05515770Phase 3Recruiting

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

Role: lead

NCT05674682Not ApplicableCompleted

Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study

Role: lead

NCT05299645Not ApplicableUnknown

The BeT Study Intervention to Reduce Disparities in HIV Prevention and Care

Role: lead

NCT03610399Not ApplicableCompleted

Efficacy of 3 Regimens of Chloroquine and Primaquine for Treatment of P. Vivax Malaria, Cruzeiro do Sul, Acre, Brazil

Role: collaborator

NCT04807699Unknown

Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL

Role: lead

NCT02600767Not ApplicableCompleted

Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil

Role: collaborator

NCT02517632Phase 3Completed

Physical Exercise Program in Chronic Chagas Heart Disease

Role: lead

NCT02516293Phase 2Completed

Cardiac Rehabilitation in Chagas Heart Failure

Role: lead

All 8 trials loaded